GlassScriptPhysician profile
Michael Gottlieb
NPI 1871506808
$191,257.71
in general payments reported to CMS, 2019-2025
48 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83K · 2020: $36K · 2021: $29K · 2022: $34K · 2023: $9,133 · 2024: $131 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,580 · Consulting Fee: $2,450 · Food and Beverage: $1,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,580.00 |
| Consulting Fee | $2,450.00 |
| Food and Beverage | $1,456.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $77,415.87 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $69,258.20 | 2019-2025 | Delstrigo, Pifeltro |
| Gilead Sciences, INC. | $17,345.99 | 2019-2025 | Veklury |
| Janssen Products, LP | $11,416.77 | 2019 | |
| Theratechnologies INC. | $5,161.37 | 2019-2023 | Trogarzo, Egrifta |
| Emd Serono, INC. | $5,033.25 | 2019-2023 | Serostim |
| Abbvie INC. | $824.40 | 2019-2025 | |
| Napo Pharmaceuticals INC | $669.09 | 2019-2025 | Mytesi |
| Janssen Biotech, INC. | $646.98 | 2019-2023 | Symtuza |
| Janssen Scientific Affairs, LLC | $550.66 | 2019-2020 | |
| Antares Pharma, INC. | $227.38 | 2019-2023 | Nocdurna, Xyosted, Tlando |
| Amgen INC. | $222.87 | 2019-2022 | |
| Allergan, INC. | $222.18 | 2019-2020 | |
| Bausch Health US, LLC | $193.95 | 2020-2023 | Aplenzin |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $179.24 | 2019-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gottlieb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.